12:00 PM
May 04, 2018
 |  BC Week In Review  |  Financial News  |  Postponed Offerings

Alzheimer's company Alzheon postpones IPO

Alzheon Inc. (Framingham, Mass.) has postponed its IPO, according to a statement to BioCentury. In March, the Alzheimer's disease company had filed for a listing on NASDAQ underwritten by Citigroup, Piper Jaffray, Canaccord Genuity and JMP Securities (see BioCentury,...

Read the full 180 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >